What’s more, STAT3 was revealed to antagonize the sensitivity of tumor cells to Palbociclib (cor = −0.406, p = 0.001), LDK-378 (cor = −0.393, p = 0.002), and Tamoxifen (cor = −0.369, p = 0.004). This evidence concerns the gene STAT3 and neoplasm.